Controlled sedation for refractory symptoms in dying patients.
about
Palliative pharmacological sedation for terminally ill adultsPain and symptom management in palliative care and at end of lifePalliative sedation for terminally ill cancer patients in a tertiary cancer center in Shanghai, China.No Negative Impact of Palliative Sedation on Relatives' Experience of the Dying Phase and Their Wellbeing after the Patient's Death: An Observational Study.Pediatric palliative sedation therapy with propofol: recommendations based on experience in children with terminal cancer.Palliative Sedation in Advanced Cancer Patients: Does it Shorten Survival Time? - A Systematic ReviewEnd-of-life issues in the acute and critically ill patientRelieving existential suffering through palliative sedation: discussion of an uneasy practice.The use of observational scales to monitor symptom control and depth of sedation in patients requiring palliative sedation: a systematic review.Death rattle: critical review and research agenda.Suboptimal palliative sedation in primary care: an exploration.Attitudes of palliative home care physicians towards palliative sedation at home in Italy.Age differences in the last week of life in advanced cancer patients followed at home.Pattern and characteristics of advanced cancer patients admitted to hospices in Italy.The use of opioids in the last week of life in an acute palliative care unit.Continuous deep sedation until death: palliation or physician-assisted death?Ethical dilemmas faced by hospice nurses when administering palliative sedation to patients with terminal cancer.At-home palliative sedation for end-of-life cancer patients.[Palliative sedation for psycho-existential suffering].A favorable course of palliative sedation: searching for indicators using caregivers' perspectives.Intensive symptom control of opioid-refractory dyspnea in congestive heart failure: Role of milrinone in the palliative care unit.Continuous palliative sedation for patients with advanced cancer at a tertiary care cancer center.Palliative sedation for status epilepticus in a patient with progressive multifocal leukoencephalopathy.Estimating the potential life-shortening effect of continuous sedation until death: a comparison between two approaches.Palliative sedation in Germany: factors and treatment practices associated with different sedation rate estimates in palliative and hospice care services.ESMO Clinical Practice Guidelines for the management of refractory symptoms at the end of life and the use of palliative sedation
P2860
Q24186758-DDED7AC9-0A62-4B3D-A22A-9551F2264A68Q26851351-0BB15E53-50D5-4C78-B282-68D46A8ACE2DQ35216505-4975A910-518D-4751-88DB-D5B6DAE3F320Q35922203-203F46F8-9AE9-46AD-A172-ACC32C199CEDQ36225242-D0F13EF2-415E-48EB-BE2E-AC3F36CA53EDQ36924213-4E7FE5E1-E6C9-4EFA-82DA-BAD9D1683547Q37455289-6B1FF7DF-8BB8-42EC-B155-C02DD944FA96Q37882754-1B19BC65-84F3-462C-BE64-73B4A721313BQ37951880-B3152BD6-F8C1-433B-9A57-1E0897807A66Q38164232-7140A2E7-3988-4393-8C74-843C126558B3Q38744171-C48368C7-8866-40A0-9FBF-3AA49A30C9F3Q39015657-848DC346-5C7F-486E-B767-F4A0885998FDQ39182044-2EE83A62-D9EB-4B4E-8248-7653A4C4BA58Q39240460-5A28CE8B-352C-4A05-8240-25E770B4598EQ39286554-EAE8CBCD-D62F-4A94-8721-CD2B0D711AC2Q39294305-9DC9131B-7E0C-40F9-9F88-D88828B5B9EFQ39669518-D2F0DA2C-401B-4FD2-886B-D223E38AB820Q43172767-16417CA5-3E9B-40BF-A464-6F87C04293ABQ43602990-AD5BE592-7189-47DD-B45C-3CA741B624F4Q43996335-E7BAC690-F750-49BE-A393-535D68963BBEQ44350925-EA76DCD5-53F9-4064-9A3A-0F3D33CC6F0CQ47169337-FB3A7B2E-A785-4EBB-A48F-975E6E97A1E5Q47797093-BBB81F4C-C98F-466D-B42D-810D55E1977EQ48208406-7830A64F-808F-4606-A9E5-6F1484B165AFQ54987103-B84CE607-A396-4B51-90CE-025F9661E837Q59273862-B2394F5D-0DCC-4F74-9051-A69724AB9CB1
P2860
Controlled sedation for refractory symptoms in dying patients.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Controlled sedation for refractory symptoms in dying patients.
@en
Controlled sedation for refractory symptoms in dying patients.
@nl
type
label
Controlled sedation for refractory symptoms in dying patients.
@en
Controlled sedation for refractory symptoms in dying patients.
@nl
prefLabel
Controlled sedation for refractory symptoms in dying patients.
@en
Controlled sedation for refractory symptoms in dying patients.
@nl
P2093
P1476
Controlled sedation for refractory symptoms in dying patients.
@en
P2093
Alessandra Casuccio
Fabrizio David
Giuseppe Intravaia
Patrizia Ferrera
Patrizia Villari
P304
P356
10.1016/J.JPAINSYMMAN.2008.04.020
P577
2008-11-28T00:00:00Z